Thursday
June 24 2021
4:54 AM
banner-icon1 banner-icon2 banner-icon3

WORLD NEWS


Previous story Now proven against coronavirus, mRNA can do so much more Next story
Published on June 1, 2021 9:36 AM

by Maggie Fox, CNN

Story Source

World Stories Search World World Index
 
If you want to make a new influenza vaccine using the traditional methods, you have to isolate the virus, learn how to grow it, learn how to inactivate it, and purify it. They are also working on two vaccines against the human immunodeficiency virus, or HIV, that causes AIDS, and one to prevent genital herpes.
 
When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted smiley face emojis to a journalist seeking his reaction. This astonishing efficacy has held up in real-world studies in the US, Israel and elsewhere. The mRNA technology -- developed for its speed and flexibility as opposed to expectations it would provide strong protection against an infectious disease -- has pleased and astonished even those who already advocated for it.

The messenger RNA, or mRNA, platform may be new to the global public, but it's a technology that researchers had been betting on for decades. Now those bets are paying off, and not just by turning back a pandemic that killed millions in just a year.

This approach that led to remarkably safe and effective vaccines against a new virus is also showing promise against old enemies such as HIV, and infections that threaten babies and young children, such as respiratory syncytial virus and metapneumovirus. It's being tested as a treatment for cancers, including melanoma and brain tumors. It might offer a new way to treat autoimmune diseases. And it's also being checked out as a possible alternative to gene therapy for intractable conditions such as sickle cell disease.

Vaccines The story of mRNA vaccines dates back to the early 1990s, when Hungarian-born researcher Katalin Kariko of the University of Pennsylvania started testing mRNA technology as a form of gene therapy. The idea is similar whether scientists want to use the mRNA molecule to cure disease or prevent it; send instructions to the cells of the body to make something specific.

Researchers like to use a cookbook analogy. The body's DNA is the cookbook. Messenger RNA is a copy of the recipe -- one that disappears quickly. In the case of genetic disease, it can be used to instruct cells to make a healthy copy of a protein. In the case of mRNA vaccines, it's used to tell cells to make what looks like a piece of virus, so the body produces antibodies and special immune system cells in response.

Kariko was unable to drum up much interest in this idea for years. But for the past 15 years or so, she's teamed up with ...